Evaluation of prognostic factors in liver-limited metastatic colorectal cancer: a preplanned analysis of the FIRE-1 trial

BACKGROUND: Liver-limited disease (LLD) denotes a specific subgroup of metastatic colorectal cancer (mCRC) patients. PATIENTS AND METHODS: A total of 479 patients with unresectable mCRC from an irinotecan-based randomised phase III trial were evaluated. Patients with LLD and non-LLD and hepatic rese...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Giessen, C, Fischer von Weikersthal, L, Laubender, R P, Stintzing, S, Modest, D P, Schalhorn, A, Schulz, C, Heinemann, V
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2013
Teme:
Clinical Study
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3776986/
https://ncbi.nlm.nih.gov/pubmed/23963138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2013.475
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items